33280 |
Death receptor 5 and tumour biotherapy |
JIANG, Xiao,ZHOU, Li-jun,WANG, Yu-hong |
2014 |
2016-08-29 |
33279 |
Research progress of methylated SEPT9 gene in the detection for colorectal cancer |
SONG, Le-le,LI, Yue-min,GONG, Yuan,HE, Bao-ming |
2014 |
2016-08-29 |
33278 |
Clinical considerations for therapeutic cancer vaccines: An introduction to FDA guidance for industry |
YANG, Ai-zhen,XIANG, Fang,JIA, Shao-chang |
2014 |
2016-08-29 |
33277 |
LYRIC in hepatocellular carcinoma: Expression and potential prognostic significance |
LI, Qi,HAN, Tao,LI, Kai,LI, Wu-sheng,ZHAO, Li,HAN, Ya-ling,XIE, Xiao-dong,ZOU, Hua-wei |
2014 |
2016-08-29 |
33276 |
Cytokine induced killer cells for gastric cancer |
SUN, Ting,TANG, Xiao-yi,LIU, Ting,ZHANG, Bin,CHEN, Hu |
2014 |
2016-08-29 |
33275 |
Expression and clinical significance of c-Myc and Bin1 in esophageal squamous cell cancer |
JIA, Yun-long,WANG, Yu,WANG, Ting-ting,DUAN, Yu-qing,WANG, Miao,WANG, Hong-yan,MENG, Xian-li,LIU, Li-hua |
2014 |
2016-08-29 |
33274 |
Dendritic cells in combination with cytokine-induced killer cells in the treatment of stage Ⅱ-Ⅳ esophageal cancer |
WANG, Dan-hong,ZHANG, Bin,GAO, Hai-yan,DING, Guo-liang,CHEN, Hu |
2014 |
2016-08-29 |
33273 |
Effects of target cell overexpression of IL-15, 4-1BBL and IL-18 combine with IL-2 on NK cell activation and cytotoxicity during ex vivo expansion |
YE, Lin-jie,HUANG, Qing-sheng,LI, Qi,ZHANG, Ming-jie,MA, Xu-dong,YANG, Hui,SHI, Jun-ling |
2014 |
2016-08-29 |
33272 |
Clinicopathological, diagnostic and prognostic significance of kallikrein 10 and vascular endothelial growth factor expression in ovarian carcinoma |
ZHOU, Ming,ZHANG, Yu-quan |
2014 |
2016-08-29 |
33271 |
Promoter region CpG island methylation status and protein levels of NDRG1 and NDRG2 in laryngeal squamous cell carcinoma |
LAN, Li-li,ZHAO, Rui-li,LIU, Meng,XU, Yu-ru |
2014 |
2016-08-29 |
